Envision Healthcare Co. (EVHC) Receives Average Rating of “Hold” from Analysts
Envision Healthcare Co. (NYSE:EVHC) has been assigned an average rating of “Hold” from the nineteen analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $38.64.
Several brokerages have recently commented on EVHC. Zacks Investment Research upgraded shares of Envision Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. Stephens reaffirmed a “hold” rating and set a $34.00 price objective on shares of Envision Healthcare in a report on Wednesday, January 10th. ValuEngine downgraded shares of Envision Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Cantor Fitzgerald reaffirmed a “hold” rating and set a $37.00 price objective on shares of Envision Healthcare in a report on Friday, January 5th. Finally, KeyCorp decreased their price objective on shares of Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating for the company in a report on Thursday, November 2nd.
A number of institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. boosted its holdings in Envision Healthcare by 1.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after purchasing an additional 70 shares during the period. M&T Bank Corp boosted its holdings in Envision Healthcare by 2.7% in the 2nd quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock valued at $341,000 after purchasing an additional 141 shares during the period. Profund Advisors LLC boosted its holdings in Envision Healthcare by 5.0% in the 2nd quarter. Profund Advisors LLC now owns 5,102 shares of the company’s stock valued at $320,000 after purchasing an additional 241 shares during the period. Phocas Financial Corp. raised its stake in shares of Envision Healthcare by 0.4% in the 2nd quarter. Phocas Financial Corp. now owns 101,263 shares of the company’s stock valued at $6,346,000 after buying an additional 427 shares in the last quarter. Finally, Green Square Capital LLC raised its stake in shares of Envision Healthcare by 3.1% in the 2nd quarter. Green Square Capital LLC now owns 16,771 shares of the company’s stock valued at $1,051,000 after buying an additional 508 shares in the last quarter.
Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. During the same quarter last year, the company earned $1.13 EPS. The business’s revenue for the quarter was up 142.0% compared to the same quarter last year. research analysts forecast that Envision Healthcare will post 2.49 earnings per share for the current year.
WARNING: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2018/01/19/envision-healthcare-co-evhc-receives-average-rating-of-hold-from-analysts.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.